Back to leadership team
Bram van Dijck is Chief Executive Officer of our business unit Cerba Research The Netherlands. He joined the company on the 1st of November 2023.
Bram has studied economics and business administration (MBA, INSEAD) and gained an extensive international experience in Life Sciences (Pharma, MedTech, Biotech) and Healthcare of which about 25 years in senior management positions in small, mid-sized and large companies.
In 2013 he started his own consultancy and interim management company.
Professional Experience
- CEO, Cerba Research The Netherlands (2023 – present)
- Managing Director, BizMed Solutions (2014 – present)
- CEO, Intergrin (2021 – 2023)
- CEO a.i., PureIMS (2020 -2021)
- Vice President – Global Head Portfolio Development, Grünenthal Group (2017 – 2020)
- Business Development Officer a.i., Radboud Translational Medicine (2017)
- Launch Manager Europe & Commercial Lead Germany a.i., BioQ Pharma Incorporated (2016 – 2017)
- CEO a.i., Therasolve NV (2015 – 2016)
- Head Hospital Business a.i., Cipla (2014 – 2016)
- Regional Managing Director UK, IR, Benelux, Germany, Lead Strategic BD & M&A EMEA, Hospira (2011 – 2013)
- Head of Hospital & Specialty Business Europe, Teva Pharmaceuticals (2008 – 2011)
- Executive Director Global Business Development, Organon International / Akzo Nobel (2006 – 2007)
- Director, Nobilon International / Akzo Nobel (2002 – 2006)
- Global Group Director Fertility, Organon (1998 – 2002)
- General Manager, BASF Pharma / Knoll Netherlands (1995 – 1998)
- Marketing Director & Business Unit Manager, Abbott Belgium (1993 – 1995)
- Product Management & Sales Management, Abbott The Netherlands (1987 – 1993)